Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC
Clinical trial NCT04648189 · WITHDRAWN
Trial details
- NCT number
- NCT04648189
- Sponsor
- The Netherlands Cancer Institute
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2022-09-19
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.